Toward a comprehensive neurobiology of IGF‐I
Open Access
- 22 February 2010
- journal article
- review article
- Published by Wiley in Developmental Neurobiology
- Vol. 70 (5), 384-396
- https://doi.org/10.1002/dneu.20778
Abstract
Insulin‐like growth factor I (IGF‐I) belongs to an ancient family of hormones already present in early invertebrates. The insulin family is well characterized in mammals, although new members have been described recently. Since its characterization over 50 years ago, IGF‐I has been considered a peptide mostly involved in the control of body growth and tissue remodeling. Currently, its most prominent recognized role is as a quasi‐universal cytoprotectant. This role connects IGF‐I with regulation of lifespan and with cancer, two areas of very active research in relation to this peptide. In the brain, IGF‐I was formerly considered a neurotrophic factor involved in brain growth, as many other neurotrophic factors. Other aspects of the neurobiology of IGF‐I are gradually emerging and suggest that this growth factor has a prominent role in brain function as a whole. During development IGF‐I is abundantly expressed in many areas, whereas once the brain is formed its expression is restricted to a few regions and in very low quantities. However, the adult brain appears to have an external input from serum IGF‐I, where this anabolic peptide is abundant. Thus, serum IGF‐I has been proven to be an important modulator of brain activity, including higher functions such as cognition. Many of these functions can be ascribed to its tissue‐remodeling activity as IGF‐I modulates adult neurogenesis and angiogenesis. Other activities are cytoprotective; indeed, IGF‐I can be considered a key neuroprotective peptide. Still others pertain to the functional characteristics of brain cells, such as cell excitability. Through modulation of membrane channels and neurotransmission, IGF‐I impinges directly on neuronal plasticity, the cellular substrate of cognition. However, to fully understand the role of IGF‐I in the brain, we have to sum the actions of locally produced IGF‐I to those of serum IGF‐I, and this is still pending. Thus, an integrated view of the role played by IGF‐I in the brain is not yet possible. An operational approach to overcome this limitation would be to consider IGF‐I as a signal coupling environmental influences on body metabolism with brain function. Or in a more colloquial way, we may say that IGF‐I links body “fitness” with brain fitness, providing a mechanism to the roman saying “mens sana in corpore sano.” © 2010 Wiley Periodicals, Inc. Develop Neurobiol 2010This publication has 118 references indexed in Scilit:
- Resistance to age-dependent thymic atrophy in long-lived mice that are deficient in pregnancy-associated plasma protein AProceedings of the National Academy of Sciences of the United States of America, 2009
- Insulin Receptor Dysfunction Impairs Cellular Clearance of Neurotoxic Oligomeric AβPublished by Elsevier BV ,2009
- Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate UptakeNeuron, 2009
- Hypercholesterolemia-induced Aβ accumulation in rabbit brain is associated with alteration in IGF-1 signalingNeurobiology of Disease, 2008
- Regulation of Amyloid β-Protein Precursor by Phosphorylation and Protein InteractionsJournal of Biological Chemistry, 2008
- SirT1 Inhibition Reduces IGF-I/IRS-2/Ras/ERK1/2 Signaling and Protects NeuronsCell Metabolism, 2008
- Regulation of muscle mass by growth hormone and IGF‐IBritish Journal of Pharmacology, 2008
- Amyloid β-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysinCellular and Molecular Life Sciences, 2008
- Functionally significant insulin-like growth factor I receptor mutations in centenariansProceedings of the National Academy of Sciences of the United States of America, 2008
- A C. elegans mutant that lives twice as long as wild typeNature, 1993